Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07815938) titled 'Immune Monitoring-Guided Individualized Tacrolimus Therapy in Renal Transplant Recipients: An Observational Study and PK/PD Modeling' on Sept. 6.

Study Type: Observational [Patient Registry]

Primary Sponsor: Zhongnan Hospital

Condition: Transplant Recipient (Kidney)

Intervention: Other: No interventional treatment, only observational data collection without clinical drug adjustment

Recruitment Status: Not recruiting

Date of First Enrollment: September 1, 2026

Target Sample Size: 50

To know more, visit https://clinicaltrials.gov/study/NCT07815938

Published by HT Digital Content Services with permission fr...